-
Luke Bilton posted an update in the group Manufacturing
Pfizer and Samsung Biologics agree $411 Million CDMO partnership for manufacturing Biosimilars
pharmasource.global
Pfizer and Samsung Biologics agree $411 Million biosimilar manufacturing partnership - PharmaSource
Samsung Biologics has entered into a strategic partnership for the long-term commercial manufacturing of Pfizer’s multi-product biosimilars portfolio. Under the new deal, valued at $411…